Lilienkampf A - Search Results

1

Alghamdi ZS, Klausen M, Gambardella A, Lilienkampf A, Bradley M. Alghamdi ZS, et al. Among authors: lilienkampf a. Org Lett. 2023 May 5;25(17):3104-3108. doi: 10.1021/acs.orglett.3c00955. Epub 2023 Apr 21. Org Lett. 2023. PMID: 37083299 Free PMC article.

2

NOC chemistry for tuberculosis-further investigations on the structure-activity relationships of antitubercular isoxazole-3-carboxylic acid ester derivatives.

Pieroni M, Lilienkampf A, Wang Y, Wan B, Cho S, Franzblau SG, Kozikowski AP. Pieroni M, et al. Among authors: lilienkampf a. ChemMedChem. 2010 Oct 4;5(10):1667-72. doi: 10.1002/cmdc.201000169. ChemMedChem. 2010. PMID: 20718072 No abstract available.

3

Derivatives of 3-isoxazolecarboxylic acid esters: a potent and selective compound class against replicating and nonreplicating Mycobacterium tuberculosis.

Lilienkampf A, Pieroni M, Franzblau SG, Bishai WR, Kozikowski AP. Lilienkampf A, et al. Curr Top Med Chem. 2012;12(7):729-34. doi: 10.2174/156802612799984544. Curr Top Med Chem. 2012. PMID: 22283815 Review.

4

A 3D QSAR model of 17beta-HSD1 inhibitors based on a thieno[2,3-d]pyrimidin-4(3H)-one core applying molecular dynamics simulations and ligand-protein docking.

Karkola S, Lilienkampf A, Wähälä K. Karkola S, et al. Among authors: lilienkampf a. ChemMedChem. 2008 Mar;3(3):461-72. doi: 10.1002/cmdc.200700271. ChemMedChem. 2008. PMID: 18224704

5

Active site analysis of 17beta-hydroxysteroid dehydrogenase type 1 enzyme complexes with SPROUT.

Alho-Richmond S, Lilienkampf A, Wähälä K. Alho-Richmond S, et al. Among authors: lilienkampf a. Mol Cell Endocrinol. 2006 Mar 27;248(1-2):208-13. doi: 10.1016/j.mce.2005.12.004. Epub 2006 Jan 10. Mol Cell Endocrinol. 2006. PMID: 16412556

6

Synthesis and biological evaluation of 17beta-hydroxysteroid dehydrogenase type 1 (17beta-HSD1) inhibitors based on a thieno[2,3-d]pyrimidin-4(3H)-one core.

Lilienkampf A, Karkola S, Alho-Richmond S, Koskimies P, Johansson N, Huhtinen K, Vihko K, Wähälä K. Lilienkampf A, et al. J Med Chem. 2009 Nov 12;52(21):6660-71. doi: 10.1021/jm900928k. J Med Chem. 2009. PMID: 19824648

7

Synthesis, biological evaluation, and structure-activity relationships for 5-[(E)-2-arylethenyl]-3-isoxazolecarboxylic acid alkyl ester derivatives as valuable antitubercular chemotypes.

Pieroni M, Lilienkampf A, Wan B, Wang Y, Franzblau SG, Kozikowski AP. Pieroni M, et al. Among authors: lilienkampf a. J Med Chem. 2009 Oct 22;52(20):6287-96. doi: 10.1021/jm900513a. J Med Chem. 2009. PMID: 19757815

8

Structure-activity relationships for a series of quinoline-based compounds active against replicating and nonreplicating Mycobacterium tuberculosis.

Lilienkampf A, Mao J, Wan B, Wang Y, Franzblau SG, Kozikowski AP. Lilienkampf A, et al. J Med Chem. 2009 Apr 9;52(7):2109-18. doi: 10.1021/jm900003c. J Med Chem. 2009. PMID: 19271749

9

Rational design of 5-phenyl-3-isoxazolecarboxylic acid ethyl esters as growth inhibitors of Mycobacterium tuberculosis. a potent and selective series for further drug development.

Lilienkampf A, Pieroni M, Wan B, Wang Y, Franzblau SG, Kozikowski AP. Lilienkampf A, et al. J Med Chem. 2010 Jan 28;53(2):678-88. doi: 10.1021/jm901273n. J Med Chem. 2010. PMID: 20000577

10

Solid-phase synthesis of arginine-based double-tailed cationic lipopeptides: potent nucleic acid carriers.

Liberska A, Lilienkampf A, Unciti-Broceta A, Bradley M. Liberska A, et al. Among authors: lilienkampf a. Chem Commun (Camb). 2011 Dec 28;47(48):12774-6. doi: 10.1039/c1cc15805h. Epub 2011 Nov 1. Chem Commun (Camb). 2011. PMID: 22045294

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

47 results

Search Page

Filters